Literature DB >> 3156086

Analysis of contact sensitivity to 2,4-dinitrofluorobenzene (DNFB) in allogeneic bone marrow chimaera in mice.

R Yasumizu, K Onoé, K Iwabuchi, M Ogasawara, L Geng, K Morikawa.   

Abstract

Irradiated C57BL/6 (B6) and C3H mice were reconstituted with bone marrow cells from BALB/c mice. The chimaeric mice, [BALB/c----B6] and [BALB/c----C3H], developed and expressed contact sensitivity to DNFB. The in vivo responses paralleled to proliferative responses of regional lymph node cells of the chimaeras to DNBS in vitro. Furthermore, intravenous administration of DNBS rendered the chimaeras tolerant to subsequent sensitization with DNFB. The tolerance was transferred to lightly irradiated BALB/c mice by the spleen and lymph node T cells. These results represent marked contrast to our previous observations that [B6----C3H] and [B6----AKR] chimaeras were unable to develop specific unresponsiveness to stimulation with DNFB by the intravenous route. The controversial observations seen in the chimaeras prepared by BALB/c bone marrows and those prepared by B6 cells are discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3156086      PMCID: PMC1454852     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  13 in total

1.  Tolerance and contact sensitivity to DNFB in mice. 3. Transfer of tolerance with "suppressor T cells".

Authors:  P Phanupak; J W Moorhead; H N Claman
Journal:  J Immunol       Date:  1974-10       Impact factor: 5.422

Review 2.  Suppressive mechanisms involving sensitization and tolerance in contact allergy.

Authors:  H N Claman; S D Miller; M S Sy; J W Moorhead
Journal:  Immunol Rev       Date:  1980       Impact factor: 12.988

3.  Contact sensitivity in fully allogeneic bone marrow chimera in mice, [B6----C3H].

Authors:  R Yasumizu; K Onoé; M Ogasawara; K Iwabuchi; L Geng; K Morikawa
Journal:  Asian Pac J Allergy Immunol       Date:  1984-06       Impact factor: 2.310

4.  Homologies between cell interaction molecules controlled by major histocompatibility complex- and Igh-V-linked genes that T cells use for communication; both molecules undergo "adaptive" differentiation in the thymus.

Authors:  K Yamauchi; P M Flood; A Singer; R K Gershon
Journal:  Eur J Immunol       Date:  1983-04       Impact factor: 5.532

5.  Adaptive differentiation of murine lymphocytes. I. Both T and B lymphocytes differentiating in F1 transplanted to parental chimeras manifest preferential cooperative activity for partner lymphocytes derived from the same parental type corresponding to the chimeric host.

Authors:  D H Katz; B J Skidmore; L R Katz; C A Bogowitz
Journal:  J Exp Med       Date:  1978-09-01       Impact factor: 14.307

6.  Restricted antibody formation to sheep erythrocytes of allogeneic bone marrow chimeras histoincompatible at the K end of the H-2 complex.

Authors:  K Onoé; R Yasumizu; T Oh-Ishi; M Kakinuma; R A Good; K Morikawa
Journal:  J Exp Med       Date:  1981-04-01       Impact factor: 14.307

7.  On the thymus in the differentiation of "H-2 self-recognition" by T cells: evidence for dual recognition?

Authors:  R M Zinkernagel; G N Callahan; A Althage; S Cooper; P A Klein; J Klein
Journal:  J Exp Med       Date:  1978-03-01       Impact factor: 14.307

8.  Humoral and cell-mediated immune responses in fully allogeneic bone marrow chimera in mice.

Authors:  K Onoé; G Fernandes; R A Good
Journal:  J Exp Med       Date:  1980-01-01       Impact factor: 14.307

9.  Soluble factors in tolerance and contact sensitivity to 2,4-dinitrofluorobenzene in mice. III. Histocompatibility antigens associated with the hapten dinitrophenol serve as target molecules on 2,4-dinitrofluorobenzene-immune T cells for soluble suppressor factor.

Authors:  J W Moorhead
Journal:  J Exp Med       Date:  1979-12-01       Impact factor: 14.307

10.  Hapten-specific T cell responses to 4-hydroxy-3-nitrophenyl acetyl. VIII. Suppressor cell pathways in cutaneous sensitivity responses.

Authors:  M E Sunday; B Benacerraf; M E Dorf
Journal:  J Exp Med       Date:  1981-04-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.